| PERIOD ENDING | 30-Sep-09 | 28-Jun-09 | 29-Mar-09 | 31-Dec-08 | | Total Revenue | 828,000 | 800,000 | 1,110,000 | 1,370,000 | | Cost of Revenue | 761,000 | 724,000 | 1,022,000 | 1,297,000 | | | Gross Profit | 67,000 | 76,000 | 88,000 | 73,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 62,000 | 53,000 | 70,000 | 106,000 | | Non Recurring | 2,000 | (60,000) | 56,000 | 305,000 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,000 | 83,000 | (38,000) | (338,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (76,000) | 90,000 | (41,000) | (334,000) | | Interest Expense | (65,000) | 20,000 | 23,000 | 22,000 | | Income Before Tax | (11,000) | 70,000 | (64,000) | (356,000) | | Income Tax Expense | 42,000 | 32,000 | (12,000) | 645,000 | | Minority Interest | (3,000) | (16,000) |
-
| 10,000 | | | | Net Income From Continuing Ops | (56,000) | 22,000 | (52,000) | (991,000) | | | Non-recurring Events | | Discontinued Operations | 44,000 | (184,000) | 5,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,000) | (162,000) | (47,000) | (991,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,000) | ($162,000) | ($47,000) | ($991,000) |
|
0.03% Nasdaq 
0.25 (2.18%) 
Income Statement
